Literature DB >> 2386978

Immunosuppression in murine renal cell carcinoma. I. Characterization of extent, severity and sources.

S K Gregorian1, J R Battisto.   

Abstract

Four cell-mediated immunological responses related to tumor elimination have been examined in mice injected with a transplantable renal cell carcinoma (Renca). Lymphokine-activated killer (LAK) cells generated in vitro from spleen cells of normal mice were capable of attacking Renca, EL-4, P815 and YAC-1 targets, but those from mice bearing Renca for 3 weeks could not. Natural killer activity, stimulated in vivo by administering poly(I) poly(C), was less than 50% of normal in Renca-bearing hosts. In addition, development of cytotoxic T lymphocytes to allogeneic targets was markedly inhibited in mice possessing the renal tumor. Finally, the delayed hypersensitivity response to a dermally applied hapten was approximately 70% less than normal in tumor-bearing mice, no matter whether the tumor existed subcutaneously or intrarenally. A kinetic study of the development of non-responsiveness using the LAK assay showed onset of poor response at 1 week, which became maximal within 3 weeks following receipt of tumor subcutaneously. The immunological depression was seen to be attributable in part to suppressor cells present among spleen cells but not bone marrow cells of tumor-bearing hosts. The suppressor cells prevented in vitro LAK generation by normal spleen cells and, when adoptively transferred to normal mice, they inhibited natural killer stimulation and delayed hypersensitivity generation. Another source of immunological down-regulation was provided by Renca cells themselves. Incorporation of Renca cells that had been X-irradiated with 30,000 rad into cultures of normal and Renca-derived splenic cells suppressed replication of both almost completely. Furthermore, the presence of X-irradiated Renca cells in cultures of normal spleen cells prevented development of LAK cells. Thus, the suppression seen in Renca-bearing mice derives from multiple sources and whether each is in any way related to the other has been discussed. Identification of the phenotypes of cells responsible for the lymphoid cell-mediated suppression and examination of its elimination are communicated in the companion paper.

Entities:  

Mesh:

Year:  1990        PMID: 2386978     DOI: 10.1007/bf01741403

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  51 in total

1.  A murine renal cell carcinoma.

Authors:  G P Murphy; W J Hrushesky
Journal:  J Natl Cancer Inst       Date:  1973-04       Impact factor: 13.506

2.  Lymphokine-activated killer cells: a new approach to immunotherapy of cancer.

Authors:  S Rosenberg
Journal:  J Natl Cancer Inst       Date:  1985-10       Impact factor: 13.506

3.  Suppressor cell activity in tumor-bearing mice. I. Dualistic inhibition by suppressor T lymphocytes and macrophages.

Authors:  K D Elgert; W L Farrar
Journal:  J Immunol       Date:  1978-04       Impact factor: 5.422

4.  Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.

Authors:  C C Ting; D Rodrigues
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

5.  T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.

Authors:  M J Berendt; R J North
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

6.  Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.

Authors:  H D Bear
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

7.  Successful treatment of advanced murine renal cell cancer by bicompartmental adoptive chemoimmunotherapy.

Authors:  R R Salup; T C Back; R H Wiltrout
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

8.  Adjuvant immunotherapy of established murine renal cancer by interleukin 2-stimulated cytotoxic lymphocytes.

Authors:  R R Salup; R H Wiltrout
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

9.  Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells.

Authors:  R B Herberman; M E Nunn; H T Holden; S Staal; J Y Djeu
Journal:  Int J Cancer       Date:  1977-04-15       Impact factor: 7.396

10.  T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity.

Authors:  A DiGiacomo; R J North
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  2 in total

1.  Immunosuppression in murine renal cell carcinoma. II. Identification of responsible lymphoid cell phenotypes and examination of elimination of suppression.

Authors:  S K Gregorian; J R Battisto
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

2.  T cells from late tumor-bearing mice express normal levels of p56lck, p59fyn, ZAP-70, and CD3 zeta despite suppressed cytolytic activity.

Authors:  D L Levey; P K Srivastava
Journal:  J Exp Med       Date:  1995-10-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.